anonymous
Guest
anonymous
Guest
The facts are out…. have some decency and stop perpetuating this failure.
“After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda Therapeutics is hanging up the gloves with a $185 million deal to sell off its assets and a bankruptcy filing.”
“After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda Therapeutics is hanging up the gloves with a $185 million deal to sell off its assets and a bankruptcy filing.”